Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹3104 Cr.
Stock P/E
16.9
P/B
3.9
Current Price
₹338.6
Book Value
₹ 86.9
Face Value
10
52W High
₹640.1
52W Low
₹ 335.5
Dividend Yield
1.18%

Indraprastha Medical Overview

Business

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) operates in the hospital and healthcare services sector. Its core business involves providing comprehensive medical care through its hospital facilities. The company primarily generates revenue by offering a wide range of medical services, including inpatient and outpatient consultations, diagnostic services, surgical procedures across various specialties, emergency care, and pharmacy sales. Its business model focuses on delivering quality healthcare to patients, leveraging medical professionals, advanced infrastructure, and technology.

Revenue Mix

As a hospital and healthcare services company, INDRAMEDCO's revenue largely stems from its hospital operations. While specific revenue breakdowns are not available, typical segments for a multi-specialty hospital include:

Inpatient Services: Revenue from patient admissions, room charges, surgical fees, intensive care, and specialized medical procedures.

Outpatient Services: Income from doctor consultations, routine check-ups, follow-up visits, and minor day-care procedures.

Diagnostic Services: Revenue generated from pathology, radiology (X-rays, MRI, CT scans), and other diagnostic tests.

Pharmacy & Ancillary Services: Sales of medicines, medical supplies, and other related services within the hospital premises.

The primary contribution to revenue for such a setup usually comes from inpatient services and complex surgeries.

Industry

The Indian hospital and healthcare services industry is characterized by strong demand, driven by a large and growing population, rising disposable incomes, increased health awareness, and expanding health insurance penetration. It is a fragmented market with a mix of large corporate hospital chains, standalone private hospitals, and public sector facilities. Indraprastha Medical Corporation Ltd., given its name (Indraprastha referring to the Delhi region), is likely positioned as a well-established, multi-specialty hospital group, potentially with a significant presence and brand recall in the Delhi-NCR region. It competes with other regional private hospitals and larger national hospital chains on factors like doctor quality, range of services, technology, and patient experience.

MOAT

INDRAMEDCO's potential competitive advantages include:

Brand Reputation & Trust: A long-standing presence and consistent delivery of quality healthcare can build significant patient trust and brand reputation within its target geographical area.

Doctor Talent & Expertise: The ability to attract and retain highly skilled and reputed medical professionals across various specialties is crucial for a hospital's success.

Established Referral Networks: Over time, strong relationships with referring physicians and clinics can create a steady stream of patients.

Strategic Location: Its hospital location(s) can offer convenience and accessibility to a large patient base.

Comprehensive Service Offering: Providing a wide range of medical services under one roof can be attractive to patients seeking holistic care.

Growth Drivers

Increasing Healthcare Demand: India's growing population, rising incidence of chronic diseases, and greater affordability are fundamental drivers.

Medical Tourism: Delhi-NCR is a hub for medical tourism, which can attract international patients seeking specialized treatments.

Expansion & Capacity Addition: Organic growth through increasing bed capacity, adding new medical specialties, or acquiring/setting up new facilities.

Technological Advancement: Adoption of advanced medical technologies and procedures can attract more patients and improve treatment outcomes.

Health Insurance Penetration: Growing coverage from public and private health insurance schemes makes quality healthcare more accessible to a wider demographic.

Risks

Intense Competition: The presence of numerous domestic and international hospital chains can lead to pricing pressures and a fight for talent.

Regulatory & Pricing Risks: Government interventions in healthcare pricing (e.g., caps on procedure costs, medicine prices) or changes in healthcare policies can impact profitability.

Talent Attrition & Retention: Difficulty in attracting and retaining highly skilled doctors, nurses, and allied healthcare professionals can impact service quality and operational efficiency.

High Capital Expenditure: Setting up and expanding hospital infrastructure, as well as upgrading medical equipment, requires significant capital investment.

Medical Malpractice & Litigation Risks: The inherent nature of medical services exposes hospitals to potential malpractice claims and legal challenges.

Technological Obsolescence: Rapid advancements in medical technology necessitate continuous investment to remain competitive.

Management & Ownership

As a "Corporation Ltd." and publicly listed entity (implied by ticker), ownership typically involves promoters (founding family or significant shareholders), institutional investors, and public shareholders. Specific details about the promoter group's background and the management team's experience would require a review of their annual reports and corporate filings. However, in the hospital sector, experienced management with a strong understanding of healthcare operations, patient care, and regulatory environments is crucial for sustained success.

Outlook

The outlook for Indraprastha Medical Corporation Ltd. is tied to the robust growth trajectory of the Indian healthcare sector. Strong underlying demand, increasing affordability, and a rising focus on quality healthcare present significant opportunities for established players. The company's likely strong regional presence and brand reputation could allow it to benefit from these trends. However, the business operates in a highly competitive, capital-intensive, and regulated environment. Key challenges include managing pricing pressures, continuous investment in technology and infrastructure, attracting and retaining top medical talent, and navigating evolving regulatory landscapes. Success will depend on its ability to maintain high service quality, optimize operational efficiency, and strategically expand its offerings while effectively managing costs and competitive dynamics.

Indraprastha Medical Share Price

Live · BSE / NSE · Inception: 1988
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Indraprastha Medical Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 315 348 350 325 334 365 381 372 365 406
Other Income 5 5 6 5 6 7 7 7 7 8
Total Income 320 353 356 330 340 372 388 379 372 415
Total Expenditure 266 281 286 273 272 292 310 310 304 326
Operating Profit 53 72 70 57 68 80 79 69 68 88
Interest 2 2 2 2 1 2 2 1 1 2
Depreciation 10 11 11 11 11 10 11 11 11 12
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 42 60 57 45 55 68 66 56 55 75
Provision for Tax 10 15 15 12 14 17 17 15 13 19
Profit After Tax 31 45 42 33 41 51 49 41 42 56
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 31 45 42 33 41 51 49 41 42 56
Adjusted Earnings Per Share 3.4 4.9 4.6 3.6 4.5 5.6 5.4 4.5 4.5 6.1

Indraprastha Medical Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 755 766 753 788 831 613 888 1099 1245 1356 1483 1524
Other Income 2 0 1 0 1 1 3 10 17 23 29 29
Total Income 758 766 753 789 831 614 891 1109 1262 1379 1511 1554
Total Expenditure 676 687 680 707 744 573 774 948 1051 1112 1216 1250
Operating Profit 81 79 74 81 87 41 117 161 210 267 296 304
Interest 7 8 9 7 6 3 3 4 4 6 6 6
Depreciation 35 31 31 30 33 33 35 39 40 44 44 45
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 39 41 34 45 48 4 79 117 166 216 246 252
Provision for Tax 14 15 13 16 5 2 20 31 42 55 62 64
Profit After Tax 24 26 21 28 44 2 59 86 124 161 184 188
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 24 26 21 28 44 2 59 86 124 161 184 188
Adjusted Earnings Per Share 2.7 2.9 2.3 3.1 4.8 0.3 6.4 9.4 13.5 17.6 20 20.5

Indraprastha Medical Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 224 231 232 244 268 273 325 379 478 597 740
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 2 0 21 15 0 0 0 0 0 0 0
Other Non-Current Liabilities 44 42 41 39 42 43 43 46 80 76 81
Total Current Liabilities 191 186 138 124 140 116 94 130 165 179 170
Total Liabilities 460 458 432 422 449 432 462 555 723 852 991
Fixed Assets 301 296 294 280 303 283 277 275 347 328 365
Other Non-Current Assets 7 5 5 7 5 7 26 57 68 92 210
Total Current Assets 152 158 133 136 141 141 159 223 308 431 417
Total Assets 460 458 432 422 449 432 462 555 723 852 991

Indraprastha Medical Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 3 2 2 3 17 20 25 42 52 62 61
Cash Flow from Operating Activities 62 28 48 75 86 27 94 144 200 157 167
Cash Flow from Investing Activities -33 -22 -30 -17 -40 -19 -74 -108 -158 -111 -178
Cash Flow from Financing Activities -30 -5 -17 -44 -43 -3 -3 -26 -32 -46 -46
Net Cash Inflow / Outflow -0 -0 1 14 4 5 17 11 9 -0 -57
Closing Cash & Cash Equivalent 2 2 3 17 20 25 42 52 62 61 5

Indraprastha Medical Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 2.67 2.86 2.3 3.1 4.76 0.25 6.39 9.4 13.52 17.56 20.03
CEPS(Rs) 6.52 6.19 5.65 6.35 8.36 3.89 10.21 13.68 17.89 22.4 24.79
DPS(Rs) 1.8 1.8 1.5 1.6 0 0 2.5 3 4.5 4.5 4
Book NAV/Share(Rs) 24.41 25.18 25.34 26.62 29.21 29.75 35.5 41.39 52.12 65.09 80.76
Core EBITDA Margin(%) 10.51 10.29 9.67 10.25 10.4 6.57 12.87 13.72 15.53 18.01 18
EBIT Margin(%) 6.11 6.36 5.7 6.53 6.51 1.24 9.29 11.06 13.67 16.41 17
Pre Tax Margin(%) 5.13 5.33 4.52 5.66 5.8 0.7 8.9 10.67 13.35 15.95 16.59
PAT Margin (%) 3.23 3.43 2.8 3.6 5.25 0.38 6.6 7.84 9.96 11.87 12.39
Cash Profit Margin (%) 7.91 7.41 6.88 7.38 9.22 5.81 10.53 11.42 13.18 15.14 15.33
ROA(%) 5.42 5.71 4.74 6.65 10.01 0.53 13.12 16.94 19.39 20.45 19.93
ROE(%) 11.68 11.55 9.11 11.93 17.05 0.86 19.6 24.44 28.92 29.97 27.47
ROCE(%) 17.72 16.98 14.4 18.29 20.15 2.8 27.58 34.46 39.7 41.43 37.7
Receivable days 39.26 43.64 44.32 37.2 34.13 43.6 22.76 18.54 18.57 18.01 23.1
Inventory Days 5.32 4.65 4.62 4.04 4.48 6.19 3.85 3.06 2.34 1.95 1.83
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 19.49 18.53 20.98 12.37 7.13 211.45 9.14 8.27 12.7 21.98 18.55
Price/Book(x) 2.13 2.11 1.91 1.44 1.16 1.81 1.65 1.88 3.3 5.93 4.6
Dividend Yield(%) 3.46 3.39 3.11 4.17 0 0 4.28 3.86 2.62 1.17 1.08
EV/Net Sales(x) 0.69 0.71 0.66 0.44 0.35 0.76 0.53 0.53 1.08 2.37 2.12
EV/Core EBITDA(x) 6.41 6.9 6.8 4.31 3.34 11.36 3.98 3.63 6.42 12.05 10.63
Net Sales Growth(%) 5.74 1.36 -1.71 4.72 5.4 -26.17 44.8 23.7 13.29 8.97 9.3
EBIT Growth(%) -19.92 5.53 -11.94 20.02 5.08 -85.9 981 47.26 40.1 30.8 13.23
PAT Growth(%) -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.88 46.96 43.89 29.87 14.06
EPS Growth(%) -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.62 46.96 43.89 29.87 14.06
Debt/Equity(x) 0.23 0.29 0.28 0.09 0.01 0 0 0 0 0 0
Current Ratio(x) 0.8 0.85 0.96 1.09 1.01 1.22 1.7 1.72 1.86 2.41 2.46
Quick Ratio(x) 0.75 0.8 0.89 1.03 0.93 1.14 1.59 1.66 1.82 2.37 2.41
Interest Cover(x) 6.22 6.16 4.82 7.49 9.14 2.28 24.19 28.38 41.91 35.5 41.87
Total Debt/Mcap(x) 0.11 0.14 0.15 0.06 0.01 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +9% +11% +19% +7%
Operating Profit CAGR +11% +23% +48% +14%
PAT CAGR +14% +29% +147% +23%
Share Price CAGR -26% +25% +34% +20%
ROE Average +27% +29% +26% +18%
ROCE Average +38% +40% +36% +25%

Indraprastha Medical Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 51 %
FII 2.77 %
DII (MF + Insurance) 0.59 %
Public (retail) 45.65 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 51515151515151515151
FII 1.081.72.642.882.942.722.412.732.442.77
DII 4.913.153.23.193.563.563.510.830.870.59
Public 43.0144.1543.1642.9342.5142.7243.0845.4445.6945.65
Others 0000000000
Total 100100100100100100100100100100

Indraprastha Medical Peer Comparison

Hospital & Healthcare Services Edit Columns

Indraprastha Medical Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Indraprastha Medical Pros & Cons

Pros

  • Company has delivered good profit growth of 147% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29%
  • Company is almost debt free.

Cons

  • Stock is trading at 3.9 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp